Earth Science Tech Inc. (OTC: ETST), a holding company focused on healthcare, announced significant operational milestones for its fiscal year ended March 31, 2026. The company reported the repurchase and retirement of more than 6.9 million shares of common stock since the first fiscal quarter of 2026, reflecting management's commitment to reducing share dilution and enhancing shareholder value. The annual shareholder letter, available at this link, detailed these achievements.
Key operating businesses—DOConsultation, Villas Health, and MOC Teledoc—have achieved cash-flow positivity, underscoring the company's focus on operational efficiency. Additionally, Peaks Curative, a health and wellness segment, surpassed $2 million in revenue during the first week of fiscal Q4 2026, reflecting robust growth in that division. These expansions were completed without adding debt to the balance sheet, maintaining a disciplined capital structure that CEO Giorgio R. Saumat emphasized in the shareholder letter.
Earth Science Tech has transformed from a wellness-focused enterprise into a strategic healthcare-oriented holding company, with interests in pharmaceutical compounding, telemedicine, real estate, and cash-flow-generating operating businesses. The fiscal 2026 results demonstrate the company's ability to scale its platform while prioritizing financial stability. Investors will have the opportunity to hear directly from management when CEO Saumat presents at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17.
The company's share repurchase program has been a defining element of its capital allocation strategy, and the retirement of over 6.9 million shares signals confidence in the company's valuation and future prospects. The disciplined approach to growth, combined with cash-flow-positive operations, positions Earth Science Tech for continued expansion without the burden of interest expenses. Further updates and news about ETST can be found in the company's newsroom at https://ibn.fm/ETST.
Earth Science Tech's fiscal 2026 results highlight the successful execution of its transformation strategy, with a focus on generating sustainable revenue and maintaining a strong balance sheet. As the company continues to expand its healthcare platform, the absence of debt and ongoing share repurchases could provide a solid foundation for long-term shareholder value.
